Zhi Gang Yan
Chairman bei Shenzhen Main Luck Pharmaceuticals, Inc.
Profil
Zhi Gang Yan is currently the Chairman at Shenzhen Main Luck Pharmaceuticals, Inc., the Director at Sichuan Industrial Institute of Antibiotics Co. Ltd., the Executive Director at Sinopharm Holding Guangzhou Co., Ltd., the Manager at Guizhou Medicine Co., and the Deputy General Manager at Shenzhen Medicine Co. His former positions include being the Director & General Manager at China National Accord Medicines Corp.
Ltd., a Director at Sinopharm YiXin Pharmaceutical Co., Ltd., and the General Manager at Sinopharm Zhijun (Shenzhen) Pharmaceutical Co. Ltd.
Aktive Positionen von Zhi Gang Yan
| Unternehmen | Position | Beginn |
|---|---|---|
| Shenzhen Main Luck Pharmaceuticals, Inc. | Chairman | 01.05.2010 |
| Sichuan Industrial Institute of Antibiotics Co. Ltd. | Director/Board Member | 03.06.2010 |
| Guizhou Medicine Co. | Corporate Officer/Principal | 09.12.2010 |
| Shenzhen Medicine Co. | Corporate Officer/Principal | 09.12.2010 |
Sinopharm Holding Guangzhou Co., Ltd.
 Sinopharm Holding Guangzhou Co., Ltd. Medical DistributorsDistribution Services Sinopharm Medicine Holding Guangzhou Co., Ltd. is a holding company that engages in drug distribution. It has offices within China. The company was founded in 2003 and is headquartered in Guangzhou, CN. | Director/Board Member | 01.02.2014 |
Ehemalige bekannte Positionen von Zhi Gang Yan
| Unternehmen | Position | Ende |
|---|---|---|
Sinopharm Zhijun (Shenzhen) Pharmaceutical Co. Ltd.
 Sinopharm Zhijun (Shenzhen) Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Sinopharm Zhijun (Shenzhen) Pharmaceutical Co. Ltd. manufactures and supplies cephalosporin. The company is headquartered in Shenzhen, China. | President | 01.12.2008 |
Sinopharm YiXin Pharmaceutical Co., Ltd.
 Sinopharm YiXin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sinopharm Holding A-Think Pharmaceutical Co., Ltd. engages in the manufacture and sale of injection mannose peptide. Its products and services include Octreotide acetate injection, Adenosine monophosphate for injection, Leucovorin for injection, Ondansetron hydrochloride injection, Sodium norcantharidin for injection, Norcantharidin tablet, Total saponin of ginseng stem and leaf tablets, Ginseng stems and leaves total saponin capsules, Vinorelbine tartaric acid for injection, and Poly-long-acting anti-bacterial membrane liquid material. The company was founded on December 10, 1997 and is headquartered in Changchun, China. | Director/Board Member | - |
| CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD. | Chief Executive Officer | 09.03.2016 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Sinopharm Holding Guangzhou Co., Ltd.
Sinopharm Holding Guangzhou Co., Ltd. Medical DistributorsDistribution Services Sinopharm Medicine Holding Guangzhou Co., Ltd. is a holding company that engages in drug distribution. It has offices within China. The company was founded in 2003 and is headquartered in Guangzhou, CN. | Distribution Services |
| Shenzhen Main Luck Pharmaceuticals, Inc. | |
Sinopharm Zhijun (Shenzhen) Pharmaceutical Co. Ltd.
Sinopharm Zhijun (Shenzhen) Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Sinopharm Zhijun (Shenzhen) Pharmaceutical Co. Ltd. manufactures and supplies cephalosporin. The company is headquartered in Shenzhen, China. | Health Technology |
| Guizhou Medicine Co. | |
| Shenzhen Medicine Co. | |
Sinopharm YiXin Pharmaceutical Co., Ltd.
Sinopharm YiXin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sinopharm Holding A-Think Pharmaceutical Co., Ltd. engages in the manufacture and sale of injection mannose peptide. Its products and services include Octreotide acetate injection, Adenosine monophosphate for injection, Leucovorin for injection, Ondansetron hydrochloride injection, Sodium norcantharidin for injection, Norcantharidin tablet, Total saponin of ginseng stem and leaf tablets, Ginseng stems and leaves total saponin capsules, Vinorelbine tartaric acid for injection, and Poly-long-acting anti-bacterial membrane liquid material. The company was founded on December 10, 1997 and is headquartered in Changchun, China. | Health Technology |
| Sichuan Industrial Institute of Antibiotics Co. Ltd. |
